OSD Capabilities Overview

Navigating the complexities of oral solid dose (OSD) drug development requires a careful balance of phase-appropriate formulation, process optimization, and scalable commercial manufacturing. Accessing a comprehensive global network of specialized facilities allows drug developers to effectively manage molecules ranging from low to highly potent compounds, controlled substances, and segregated hormones.

Early-phase activities leverage digital modeling, solubility enhancement technologies, and compaction simulations to establish technical certainty before expanding into large-scale production. As programs advance, integrating specialized dosage forms—such as continuous manufacturing, softgels, multiparticulates, and fixed-dose combinations—customizes the development pathway to a molecule's unique properties. Combining these robust manufacturing capabilities with end-to-end regulatory support, clinical trial logistics, and commercial packaging streamlines the entire lifecycle, successfully reducing time-to-market.